Royce & Associates’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.53M | Buy |
|
|||||
|
2025
Q1 | $1.21M | Buy |
|
|||||
|
2024
Q4 | $1.4M | Buy |
|
|||||
|
2024
Q3 | $1.26M | Buy |
|
|||||
|
2024
Q2 | $1.23M | Buy |
|
|||||
|
2024
Q1 | $1.26M | Buy |
|
|||||
|
2023
Q4 | $1.36M | Buy |
|
|||||
|
2023
Q3 | $1.27M | Sell |
|
|||||
|
2023
Q2 | $1.46M | Sell |
|
|||||
|
2023
Q1 | $1.48M | Buy |
|
|||||
|
2022
Q4 | $1.12M | Buy |
|
|||||
|
2022
Q3 | $775K | Buy |
|
|||||
|
2022
Q2 | $471K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $302K | Sell |
|
|||||
|
2021
Q1 | $354K | Sell |
|
|||||
|
2020
Q4 | $328K | Buy |
|
|||||
|
2020
Q3 | $269K | Buy |
|
|||||
|
2020
Q2 | $266K | Buy |
|
|||||
|
2020
Q1 | $209K | Sell |
|
|||||
|
2019
Q4 | $289K | Buy |
|
|||||
|
2019
Q3 | $48K | Buy |
|
|||||
|
2019
Q2 | $35K | Buy |
|
|||||
|
2019
Q1 | $32K | Buy |
|
|||||
|
2018
Q4 | $27K | Sell |
|
|||||
|
2018
Q3 | $31K | Buy |
|
|||||
|
2018
Q2 | $19K | Buy |
|
|||||
|
2018
Q1 | $12K | Sell |
|
|||||
|
2017
Q4 | $12K | Sell |
|
|||||
|
2017
Q3 | $11K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $82K | Hold |
|
|||||
|
2014
Q3 | $59K | Hold |
|
|||||
|
2014
Q2 | $63K | Hold |
|
|||||
|
2014
Q1 | $60K | Hold |
|
|||||
|
2013
Q4 | $60K | Hold |
|
|||||
|
2013
Q3 | $69K | Hold |
|
|||||
|
2013
Q2 | $58K | Buy |
|